A 12-month, Open Label, Multicenter Pilot Study Evaluating Fingolimod Treatment in terms of Patient Satisfaction in Relapsing Remitting Multiple Sclerosis Patients - FINE Trial

INTRODUCTION: To assess satisfaction and quality of life in patients with relapsing–remitting multiple sclerosis (RRMS) who were receiving fingolimod (0.5 mg/day) for 12 months as a second-line treatment after switching from injectable agents. METHODS: Patients aged 18–65 years with RRMS who fulfill...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Noro Psikiyatr Ars
Главные авторы: Demır, Gülşen Akman, Türkoğlu, Recai, Saıp, Sabahattin, Yüceyar, Nur, Efendı, Hüsnü, Turan, Ömer Faruk, Ağan, Kadriye, Terzı, Murat, Boz, Cavit, Tuncer, Aslı, Koçer, Belgin, Kasap, Mithat, Çalişkan, Zeynep
Формат: Artigo
Язык:Inglês
Опубликовано: Noro-Psikiyatri Arsivi 2017
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6927087/
https://ncbi.nlm.nih.gov/pubmed/31903032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/npa.2017.20515
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы